Moderna, Inc. (NASDAQ:MRNA) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) have earned an average recommendation of “Hold” from the eighteen brokerages that are covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation and seven have given a buy recommendation to the company. The […]

Leave a Reply

Your email address will not be published.

Previous post Carlisle Companies (CSL) Set to Announce Quarterly Earnings on Wednesday
Next post Aramark (NYSE:ARMK) Receives $34.89 Average Target Price from Brokerages